Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 5Gynecologic 2Gastrointestinal 2Head & Neck 1Dermatologic 1Breast 1

Conditions

Squamous Cell Carcinoma of Head and Neck 17Head and Neck Neoplasms 14Nasopharyngeal Carcinoma 8Carcinoma, Non-Small-Cell Lung 5Thyroid Neoplasms 4Stomach Neoplasms 4Salivary Gland Neoplasms 4Neoplasms 4Nasopharyngeal Neoplasms 4Esophageal Neoplasms 4Radiation Injuries 3Neoplasm Metastasis 3Melanoma 3Esthesioneuroblastoma, Olfactory 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Tongue Neoplasms 2Thyroid Carcinoma, Anaplastic 2Pharyngeal Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Mouth Neoplasms 2Lymphoid Interstitial Pneumonia 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Carcinoma, Merkel Cell 2Carcinoma 2

Interventions

pembrolizumab 13Nivolumab 6Docetaxel 6cemiplimab 5avelumab 5atezolizumab 5Trastuzumab 5Carboplatin 4durvalumab 3Polymerase Chain Reaction 3Magnetic Resonance Spectroscopy 3Gene Expression Profiling 3Gemcitabine 3Fluorouracil 3Cisplatin 3Biopsy 3zimberelimab 2utomilumab 2ulixertinib 2tisotumab vedotin 2pertuzumab 2palbociclib 2belinostat 2amminedichloro(2-methylpyridine)platinum(II) 2Tetrahydrouridine 2Radiotherapy 2Radiosurgery 2Oxaliplatin 2Nicotine 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Bevacizumab × Head & Neck × Clear all
NCT05007106 2025-08-14

KEYVIBE-005

Merck Sharp & Dohme LLC

Phase 2 Completed
613 enrolled
BreastGastrointestinalGenitourinaryGynecologicHead & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Ovarian Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡